Earnings · US stocks
Iovance Biotherapeutics Inc (IOVA) earnings
Iovance Biotherapeutics Inc published its quarterly report on 2026-11-05. The stock moved -6.09% in the 3 trading days after the report.
- Report
- quarterly report
- Published
- 2026-11-05
- Result
- Bad / loss
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -11.03% | — |
| 3 days | -6.09% | — |
| 7 days | -10.80% | — |
Report history
Over the last 8 reports, EPS beat the consensus estimate in 4 of them. The stock rose in the 3 trading days after 4 of 8 reports (average +8.35%).
| Published | EPS | EPS surprise | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|
| 2026-11-05 | -0.05 | +41.35% | -6.09% | — | — |
| 2026-08-06 | -0.11 | +18.43% | +47.47% | +130.88% | +131.81% |
| 2026-05-07 | -0.19 | -23.78% | -9.54% | -4.40% | -6.16% |
| 2026-02-24 | -0.18 | -2.05% | +31.14% | +14.88% | +18.27% |
| 2025-11-06 | -0.25 | +2.85% | +30.94% | +35.91% | +36.08% |
| 2025-08-07 | -0.33 | -19.37% | -15.53% | -22.35% | -27.32% |
| 2025-05-08 | -0.36 | -52.33% | +12.93% | +16.72% | +10.51% |
| 2025-02-26 | -0.26 | +2.85% | -24.49% | -38.88% | -31.15% |
The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.
Stock valuations: IOVA · Stock news: IOVA
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.